Published

Contribution of the Serotonin 5-HT2A Receptor to the Therapeutic Effect of Psilocin on Social Behavior Deficits in Mice Repeatedly Exposed to Social Defeat Stress

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Neuropsychopharmacology Reports
Date: 2026-09-01
Source: Crossref
DOI: 10.1002/npr2.70152
PubMed: 42379141

Authors

Ibi Daisuke Takaba Rika Yoshida Keisuke Kawase Ririna Kitagawa Hiroko Matsushita Momoko Ito Kana Uno Shoya Nishimura Fumiya Kitagaki Shinji Hiramatsu Masayuki

Watch author

Derived topics and classifications

psilocybin psilocin Depression Anxiety Receptor Pharmacology Resilience Animal Study Treatment-Resistant Depression Animal Study

Citation graph

19 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

10.1016/j.cell.2020.03.020 10.1001/jamapsychiatry.2020.3285 10.1007/s00210‐023‐02778‐x 10.3390/pharmaceutics17040411 10.3389/fphar.2024.1391689 10.1542/peds.2008‐1215 10.1186/s12888‐023‐04681‐4 10.1073/pnas.2312662120 10.1016/j.bpsgos.2021.12.009 10.1016/j.biopsych.2016.06.012 10.1016/j.neuroscience.2021.01.029 10.1016/j.neures.2022.12.015

Indexed papers citing this DOI

Contribution of the Serotonin 5-HT2A Receptor to the Therapeutic Effect of Psilocin on Social Behavior Deficits in Mice Repeatedly Exposed to Social Defeat Stress2026-09-01

Related papers

Could psilocin rescue chronic, stress-accelerated, transcriptional aging in brain?UKnowledge (University of Kentucky) · 2025-03-04 Neurobiological Effects of Psilocybin in Treatment Resistant Bipolar Depression: An Emotional-Processing fMRI Pilot StudyClinicalTrials.gov · 2026-08-10 Safety and Psychological Effects of Psilocybin and D-Serine Formulation in Healthy VolunteersClinicalTrials.gov · 2026-02-05 Measurement of Serum Cytokine Levels in Samples Collected as Part of a Clinical Trial of Psilocybin for Treatment-resistant Depression.ClinicalTrials.gov · 2025-09-10 Processing Intergenerational Trauma With Psilocybin-Assisted TherapyClinicalTrials.gov · 2026-08-13 TRIP - TReatment to Improve Depression and/or Anxiety Using Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance TherapyClinicalTrials.gov · 2026-08-12 TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer SurvivorsClinicalTrials.gov · 2026-08-12 Imaging the Effects of Serotonin 2A Receptor Modulation on Synaptic Density in Treatment-resistant Depression (SYNVEST)ClinicalTrials.gov · 2026-07-30